Sargent Investment Group LLC Has $3.52 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Sargent Investment Group LLC raised its stake in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 37.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 6,507 shares of the healthcare conglomerate’s stock after purchasing an additional 1,772 shares during the period. Sargent Investment Group LLC’s holdings in UnitedHealth Group were worth $3,521,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of UNH. Kathleen S. Wright Associates Inc. purchased a new stake in shares of UnitedHealth Group during the 3rd quarter worth approximately $27,000. West Financial Advisors LLC bought a new position in shares of UnitedHealth Group during the third quarter valued at about $32,000. AlphaMark Advisors LLC purchased a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $30,000. RPg Family Wealth Advisory LLC bought a new position in shares of UnitedHealth Group in the 3rd quarter worth about $37,000. Finally, Friedenthal Financial purchased a new stake in shares of UnitedHealth Group in the third quarter worth $51,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts have recently weighed in on UNH shares. Piper Sandler cut their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. Royal Bank of Canada decreased their price target on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research report on Wednesday, October 16th. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Barclays dropped their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday, January 17th. Finally, StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. One investment analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $629.32.

Read Our Latest Stock Report on UnitedHealth Group

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Stock Performance

Shares of UNH opened at $545.08 on Wednesday. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock has a market capitalization of $501.63 billion, a price-to-earnings ratio of 35.17, a price-to-earnings-growth ratio of 1.48 and a beta of 0.61. The stock’s 50-day simple moving average is $535.03 and its 200 day simple moving average is $565.09.

UnitedHealth Group (NYSE:UNHGet Free Report) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the company earned $5.83 EPS. Research analysts forecast that UnitedHealth Group Incorporated will post 29.63 EPS for the current fiscal year.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.